Wedbush Securities Inc Horizon Therapeutics Public LTD CO Transaction History

Wedbush Securities Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$62.39 - $113.8 $165,333 - $301,570	-2,650 Reduced 56.17%	2,068 $235,000
Q3 2022 Oct 18, 2022	SELL	$58.92 - $84.67 $15,967 - $22,945	-271 Reduced 5.43%	4,718 $291,000
Q2 2022 Jul 21, 2022	SELL	$79.4 - $116.36 $36,841 - $53,991	-464 Reduced 8.51%	4,989 $397,000
Q1 2022 Apr 19, 2022	BUY	$86.42 - $109.81 $12,790 - $16,251	148 Added 2.79%	5,453 $573,000
Q4 2021 Jan 13, 2022	BUY	$98.56 - $119.91 $98,757 - $120,149	1,002 Added 23.29%	5,305 $571,000
Q3 2021 Oct 08, 2021	BUY	$91.91 - $110.37 $92,185 - $110,701	1,003 Added 30.39%	4,303 $471,000
Q2 2021 Jul 27, 2021	BUY	$86.24 - $95.92 $30,787 - $34,243	357 Added 12.13%	3,300 $309,000
Q1 2021 Apr 26, 2021	BUY	$71.83 - $95.48 $211,395 - $280,997	2,943 New	2,943 $270,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.